Evidence map›Paper›PMID 22474484›Full record

ArticleClinical & developmental immunology2012

PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection.

Katie M Bryant-Hudson, Daniel J J Carr

Open access · goldAbstract read
In one paragraph

Article in Clinical & developmental immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Pathobiology and treatment of viral keratitis.Experimental eye research · 2021
    Review
  6. Updates on Oncolytic Virus Immunotherapy for Cancers.Molecular therapy oncolytics · 2019
    Article
  7. PD-L1/B7-H1 Inhibits Viral Clearance by Macrophages in HSV-1-Infected Corneas.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Katie M Bryant-HudsonDepartment of Ophthalmology, Dean McGee Eye Institute, The University of Oklahoma Health Sciences Center, Room 415, 608 Stanton L Young Boulevard, Oklahoma, OK 73104, USA.
Daniel J J Carr
Dean McGee Eye Institute · USUniversity of Oklahoma Health Sciences Center · US

Funding

UNDERSTANDING THE ROLE OF RETINOL DEHYDROGENASES RDH11 AND RDH12 IN VISIONP20RR017703 · NCRR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI MANDAL, NAWAJES · 2002 to 2011
$23.6M
Corneal Lymphatics & Adaptive ImmunityR01EY021238 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CARR, DANIEL J · 2011 to 2020
$3.6M
NCRR NIH HHS P20 RR017703NEI NIH HHS EY021238NEI NIH HHS R01 EY021238
6 · The paper itself

Abstract

The inhibitory receptor, Programmed Death 1 (PD-1), and its ligands (PD-L1/PD-L2) are thought to play a role in immune surveillance during chronic viral infection. The contribution of the receptor/ligand pair during an acute infection is less understood. To determine the role of PD-L1 and PD-L2 during acute ocular herpes simplex virus type 1 (HSV-1) infection, HSV-1-infected mice administered neutralizing antibody to PD-L1 or PD-L2 were assessed for viral burden and host cellular immune responses. Virus titers were elevated in cornea and trigeminal ganglia (TG) of anti-PD-L1-treated mice which corresponded with a reduced number of CD80-expressing dendritic cells, PD-L1⁺ dendritic cells, and HSV-1-specific CD8⁺ T cells within the draining (mandibular) lymph node (MLN). In contrast, anti-PD-L2 treatment had no effect on viral replication or changes in the MLN population. Notably, analysis of CD11c-enriched MLN cells from anti-PD-L1-treated mice revealed impaired functional capabilities. These studies indicate PD-L1-expressing dendritic cells are important for antiviral defense during acute HSV-1 infection.

Indexed as

Acute DiseaseAnimalsAntibodies, NeutralizingB7-H1 AntigenCD8-Positive T-LymphocytesCorneaDendritic CellsDisease ResistanceFemaleGene ExpressionHerpesvirus 1, HumanImmunologic SurveillanceKeratitis, HerpeticLymph NodesMaleMiceAntibodies, NeutralizingB7-H1 AntigenCd274 protein, mousePdcd1lg2 protein, mouseProgrammed Cell Death 1 Ligand 2 Protein

Identifiers

PMID22474484
PMCPMC3299487
OpenAlexW2023268555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.